upcoming glp-1 drugs What to Make of the Coverage and Cost Landscape GLP Agonist Clinical Trial Pipeline

Tilt it at slight angles

Ozempic, estimated to cost about $10,000 a year per person, and others in this class could put significant financial strain on payers as demand grows

This means staying at 0.5 mg for eight weeks instead of four, for example

For patients experiencing non-emergent back pain during GLP-1-based therapy, a systematic approach to management can often provide relief while allowing continuation of beneficial metabolic treatment

Future efforts should address affordability and accessibility through health economic analyses and policy-driven approaches

Patients Considering Compounded GLP-1 Options Telehealth providers may offer compounded GLP-1 formulations at lower upfront prices